Genmab | 销售和管理费用

Selling And Administration Expenses 更改 日
Almirall EUR 112M 4.27M 2024-03
Amarin USD 45.46M 5.5M 2023-09
Amgen USD 1.81B 44M 2024-03
AstraZeneca USD 3.91B 194M 2023-09
Bayer EUR 3.83B 234M 2024-03
BioMarin Pharmaceutical USD 225.91M 49.12M 2024-03
Demant DKK 5.49B 135M 2023-06
Exelixis USD 113.98M 24.16M 2024-03
Fresenius Medical Care EUR 775.64M 69.36M 2024-03
Galapagos EUR 30.79M 29.78M 2024-03
Genmab DKK 839M 9M 2023-09
GlaxoSmithKline GBP 2.09B 500M 2024-03
GN Store Nord DKK 1.38B 347M 2024-03
GRIFOLS EUR 353.2M 52.88M 2023-12
Hikma Pharmaceutical USD 260M 7M 2023-06
Insmed USD 93.1M 3.57M 2024-03
Merck EUR 1.42B 115M 2024-03
Regeneron Pharmaceuticals USD 689M 48.7M 2024-03
Roche Holding CHF 6.51B 26M 2023-06
UCB EUR 857M 12M 2023-06



Genmab 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.